HOME >> BIOLOGY >> NEWS
ASM and TIGR team up on microbial genomes conference

The American Society for Microbiology (ASM) and The Institute for Genomic Research (TIGR) will cosponsor the Conference on Microbial Genomes, to be held January 28-31, 2001 at the Hyatt Regency Hotel in Monterey, California.

When scientists complete the sequencing of the human genome in the next year or so, their work will have just begun. They will be faced with an enormous database listing genetic sequences that must be deciphered to have any practical use. Fortunately, bacteria often contain genes similar to those found in humans, and scientists may already know what these genes do. The smaller, less complex genomes of microbes will serve as the genomic equivalent of the Rosetta Stone to help interpret and understand the human genome.

Proteomics, the study of the expression and interaction of proteins, has taken off in the wake of microbial genome sequencing. The synergy between between these two fields will quickly shed light on how some microbes cause disease and help identify targets for new drugs. Microbial genomes will also offer important information for developing new DNA-based vaccines, gene therapies and new biodegradable chemicals for industrial processes.

Session topics include genome projects, evolution, functional genomics and bioinformatics. More detailed information, including a preliminary program and general registration information can be found online at http://www.asmusa.org/mtgsrc/MicrobialGenomesg.htm. A limited number of complimentary registrations are available to members of the press. Pre-registration is required for the media. If you are interested in attending as press please contact Jim Sliwa, ASM Office of Communications, jsliwa@asmusa.org, or by phone at (202) 942-9297.


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
18-Dec-2000


Page: 1

Related biology news :

1. Study suggests insect-derived antimicrobial peptides could be used as drug-delivery vehicles
2. Protease-inhibitor cocktail protects, increases anti-microbial action of promising new peptide
3. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
4. Plant pathologists express need for plant pathology-related microbial culture resources
5. TIGR and NIAID sign $65 million microbial sequencing contract
6. Phages point the way to novel targets for antimicrobial drug discovery
7. New research challenges prevailing theory of microbial biodiversity
8. Yeast, wormwood & bacterial genes combine in microbial factory to make antimalarial drug
9. Brookhaven Lab & Battelle collaborate on research that may lead to novel anti-microbial drugs
10. Green tea boosts antimicrobial properties of toothpaste
11. JGI and Diversa Corp. announce large-scale microbial sequencing collaboration

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ASM and TIGR team microbial genomes conference

(Date:10/16/2014)... 2014) – Post-menopausal women experienced improvements in vaginal ... or genital bleeding, after 12 weeks of daily ... soy germ-based nutritional supplement previously shown to help ... peer-reviewed pilot study reported in a poster at ... meeting. , "These data documented improved vaginal ...
(Date:10/15/2014)... non-traditional biophysics textbook and it describes how life functions ... discovery into biological systems and provides an understanding of ... about how our genes make proteins that control the ... in an organism. It quantifies the principles of life ... found on both large and small scales. The book ...
(Date:10/15/2014)... SHELTON, Conn. , Oct. 15, 2014 NXT-ID, Inc. ... a biometric authentication company focused on the growing mobile commerce market ... NASDAQ MarketSite in Times Square on Monday October 13 th . ... with CTO David Tunnel and angel investor Mr. ... Gino Pereira , CEO of NXT-ID thanked his investors and employees ...
Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2New book about life as seen from physics 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
(Date:10/22/2014)... , Oct. 22, 2014  Actavis plc (NYSE: ... and Rhythm, a biopharmaceutical company, today announced that Actavis ... wholly owned subsidiary, Rhythm Health, Inc., which is developing ... of diabetic gastroparesis and other GI functional disorders. ... trial of relamorelin for the treatment of diabetic gastroparesis ...
(Date:10/22/2014)... Involution Studios , a healthcare software design ... Understanding Ebola . The goal of the ... follow informative tool for anyone wanting to know more ... , "As the news has spread in all directions ... not only a healthcare crisis with global impact, but ...
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
Cached News: